Immunodominant peptides from conserved influenza proteins - A tool for more efficient vaccination in the elderly?

Wiener Medizinische Wochenschrift

Volumn 157, Issue 5-6, 2007, Pages 116-121

  Almanzar, Giovanni ^a   Herndler Brandstetter, Dietmar ^a   Chaparro, Sandra Vega ^a   Jenewein, Brigitte ^a   Keller, Michael ^a   Grubeck Loebenstein, Beatrix ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Aging; CD8+ T cells; Influenza

Indexed keywords

CD28 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; INFLUENZA VACCINE; PADGEM PROTEIN; PERFORIN; PROTEIN M1 58 66; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; ELDERLY CARE; HUMAN; IN VITRO STUDY; INFLUENZA VIRUS; PHENOTYPE; VACCINATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD45; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PEPTIDE FRAGMENTS; PORE FORMING CYTOTOXIC PROTEINS; VACCINATION; VACCINES, SUBUNIT; VIRAL MATRIX PROTEINS;

EID: 34247271902     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-007-0393-y     Document Type: Article

References (26)

1. Grubeck-Loebenstein B, Wick G (2002) The aging of the immune system. Adv Immunol 80: 243-284
2. Gavazzi G, Krause KH (2002) Ageing and infection. Lancet Infect Dis 2: 659-666
3. Aspinall R, Andrew D (2000) Thymic involution in aging. J Clin Immunol 20: 250-256
4. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Würzner R, Schönitzer D, Grubeck-Loebenstein B (2005) Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 79: 3675-3683
5. Bridges CB, Fukuda K, Cox NJ, Singleton JA (2001) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 50: 1-44
6. Castle SC (2000) Clinical relevance of age-related immune dysfunction. Clin Infect Dis 31: 578-585
7. Webster RG (2000) Immunity to influenza in the elderly. Vaccine 18: 1686-1689
8. Fedson DS (2004) Vaccination for pandemic influenza: a six point agenda for interpandemic years. Pediatr Infect Dis J 23: 74-77
9. McElhaney JE (2005) The unmet need in the elderly: Designing new influenza vaccines for older adults. Vaccine 23 (Suppl 1): 10-25
10. McElhaney JE, Herre JM, Lawson ML, Cole SK, Burke BL, Hooton JW (2004) Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine 22: 681-688
11. Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak LB, Machala M, Mysliwski A (2003) Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 21: 3826-3836
12. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75: 12182-12187
13. Saurwein-Teissl M, Lung TL, Marx F, Gschösser C, Asch E, Blasko I, Parson W, Böck W, Schönitzer D, Trannoy E, Grubeck-Loebenstein B (2002) Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168: 5893-5899
14. Khan N, Hislop A, Gudgeon N, Cobbold M, Khanna R, Nayak L, Rickinson AB, Moss PA (2004) Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 173: 7481-7849
15. Po JL, Gardner EM, Anaraki F, Katsikis PD, Murasko DM (2002) Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech Ageing Dev 123:1167-1181
16. Zhang Y, Wang Y, Gilmore X, Xu K, Chen M, Tebebi P, Mbawuike IN (2002) Apoptosis and reduced influenza A virus specific CD8+ T cells in aging mice. Cell Death Differ 9: 651-660
17. De Jong JC, Rimmelzwaan GF, Fouchier RA, Osterhaus AD (2000) Influenza virus: a master of metamorphosis. J Infect 40: 218-228
18. Piedra PA (1995) Influenza virus pneumonia: pathogenesis, treatment, and prevention. Semin Respir Infect 10: 216-223
19. Scholtissek C (1997) Molecular epidemiology of influenza. Arch Virol Suppl 13: 99-103
20. Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF (2002) Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 76: 2567-2572
21. Cerwenka A, Morgan TM, Dutton RW (1999) Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J Immunol 163: 5535-5543
22. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159: 105-117
23. Deng Y, Jing Y, Campbell AE, Gravenstein S (2004) Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 172: 3437-3446
24. Gschoesser C, Almanzar G, Hainz U, Ortin J, Schönitzer D, Schild H, Saurwein-Teissl M, Grubeck-Loebenstein B (2002) CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein. Vaccine 20: 3731-3738
25. Ulmer JB, Wahren B, Liu MA (2006) Gene-based vaccines: Recent technical and clinical advances. Trends Mol Med 12: 216-222
26. Taubenberger JK (2005) The virulence of the 1918 pandemic influenza virus: Unraveling the enigma. Arch Virol Suppl 19: 101-115